Life Sciences Companies divorce agrochem operations - Views on News from Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  
  • Home
  • Outlook Arena
  • Jul 14, 2000 - Life Sciences Companies divorce agrochem operations

Life Sciences Companies divorce agrochem operations

Jul 14, 2000

The wheel seems to have come a full circle for life science companies. The last year has seen an across the board spin off of their agro–chemical arms by the life science (a euphemism for a conglomerate of pharmaceutical and agrochemical operations) corporations. Novartis (formed with the merger of Ciba and Sandoz) de–merged its agro chemical arm and proposed a merger with Zeneca (the agro–chemical arm of Astra–Zeneca) to form Syngenta. Aventis Crop Science came into being with the merger of the agro–chemical arms of Hoechst Marion Roussel and Rhone Poulenc. Then American Home Products announced the sale of its agro–chemical business Cyanamid to the German specialty chemical conglomerate BASF.

Why has this happened? Why have international pharmaceutical majors gone back to the core competence mantra? Till the last year it was the pharmaceutical operations of the life science corporations, which were supposed to finance the biotech revolution. What has changed?

The answers were provided by Mr. Edward Schillinger, Managing Director, Novartis India at last week’s analysts meet. He said that there were two reasons for these developments. First, was the realisation, among life science companies, that there were hardly any synergies between the pharmaceutical operations and the agrochemical operations of the life science companies. The two catered to totally different markets and the type of personnel running the two operations were different. It was equivalent to running two businesses under the aegis of one company.

The second reason for the hive off was the pressure from the shareholders. This was due to the fact that last year was a bad year for the agrochemical business. (Even otherwise the returns from the pharmaceutical business are relatively higher than the agrochemical business.) Hence it was imperative that the shareholders interested in the pharmaceutical business were not deprived of their returns, which were otherwise getting averaged out by the lower returns from the agrochemical operations.

This would however imply that agro–chemical firms will have to fund their forays into biotech, gentology and tissue culture on their own. Mr. Schillinger, however clarified that the agrochemical businesses were not unviable businesses. These were sound businesses, which could very well finance their ambitious plans.

Infact, after the recent round of restructuring there would be around five firms, the world over which would dominate the agrochemical business. These include Monsanto (which ironically has proposed a merger with pharma major Pharmacia & Upjohn), Aventis Crop Science, Syngenta, Bayer and BASF–Cyanamid.


Equitymaster requests your view! Post a comment on "Life Sciences Companies divorce agrochem operations". Click here!

  

More Views on News

J.B.CHEMICALS Share Price Down by 5%; BSE HEALTHCARE Index Down 1.2% (Market Updates)

Sep 23, 2020 | Updated on Sep 23, 2020

J.B.CHEMICALS share price is trading down by 5% and its current market price is Rs 1,030. The BSE HEALTHCARE is down by 1.2%. The top gainers in the BSE HEALTHCARE Index are PFIZER (up 1.9%) and GLENMARK PHARMA (up 1.5%). The top losers are J.B.CHEMICALS (down 5.3%) and JUBILANT LIFE SCIENCES (down 6.3%).

ADVANCED ENZYME TECHNOLOGIES Share Price Up by 5%; BSE HEALTHCARE Index Up 0.4% (Market Updates)

Sep 23, 2020 | Updated on Sep 23, 2020

ADVANCED ENZYME TECHNOLOGIES share price is trading up by 5% and its current market price is Rs 239. The BSE HEALTHCARE is up by 0.4%. The top gainers in the BSE HEALTHCARE Index is ADVANCED ENZYME TECHNOLOGIES (up 5.2%). The top losers are LUPIN (down 0.2%) and SYNGENE INTERNATIONAL (down 0.3%).

More Views on News

Most Popular

How the 8-Year Cycle Can Help Identify Multibaggers (Fast Profits Daily)

Sep 11, 2020

This is how you can apply the greed and fear cycle in the market to pick stocks.

Why We Picked This Small-cap Stock for Our Hidden Treasure Subscribers (Profit Hunter)

Sep 17, 2020

This leading household brand will profit big time in a post covid world.

This Could Be the Best September for Auto Stocks (Profit Hunter)

Sep 11, 2020

Here's why I think this month could be a great for auto stocks.

What Do the Charts Say About Buying Smallcaps Now? (Fast Profits Daily)

Sep 18, 2020

Everyone seems to be excited about buying smallcaps now...but is it the right thing to do? What do the charts tell us? Find out in this video...

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

S&P BSE HEALTHCARE


Sep 23, 2020 (Close)

S&P BSE HEALTHCARE 5-YR ANALYSIS

COMPARE COMPANY

MARKET STATS